Ascendis Pharma (ADR) (ASND)
Builds and commercializes rare-endocrinology medicines through the TransCon prodrug platform.
$236.95
vs last close−0.65 (−0.27%)
Something off on this page? Send us feedback.
13F · 13D/G · Form 4
| Institutions | 107.97% | 66.92M ADS | |
|---|---|---|---|
| 334 holders · as of Jun 30, 2026 | |||
| Insiders | 0.83% | 514.5K ADS | |
| 11 holders · as of Sep 3, 2026 | |||
| Strategic holders | 8.58% | 5.32M ADS | |
| 2 holders · as of May 15, 2026 | |||
| Adds to | 117.38% | ||
61.98M ADS as of Sep 22, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
These groups come from separate filings that can overlap, so they add to 117.38%; nothing is left for Other.
13F, as of Jun 30, 2026
334 holders · 66.92M shares · 94 new positions · 197 increased · 92 reduced · 52 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Ra Capital Management, L.P. | 10.28M | 16.59% | +10.28Mnew | Aug 14, 2026 |
| T. Rowe Price Investment Management, Inc. | 6.75M | 10.90% | +592.8K | Aug 14, 2026 |
| Avoro Capital Advisors LLC | 5.11M | 8.25% | +5.11Mnew | Aug 14, 2026 |
| Westfield Capital Management Co LP | 4.80M | 7.74% | +4.80Mnew | Aug 12, 2026 |
| Jupiter Topco LLC | 3.65M | 5.89% | +3.65Mnew | Aug 14, 2026 |
| FMR LLC | 3.55M | 5.72% | +3.55Mnew | Aug 13, 2026 |
| Artisan Partners Limited Partnership | 2.63M | 4.25% | +2.63Mnew | Aug 13, 2026 |
| BlackRock, Inc. | 2.21M | 3.57% | +2.21Mnew | Aug 7, 2026 |
13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| T. Rowe Price Investment Management, Inc. | 9.90% | 6.16M | 13G | May 7, 2026 |
| Westfield Capital Management Company, L.P. | 8.48% | 5.19M | 13G | Feb 11, 2026 |
| FMR LLC | 8.00% | 4.65M | 13G | May 12, 2025 |
| Janus Henderson Group PLC | 6.00% | 3.72M | 13G | May 15, 2026 |
| Artisan Partners Asset Management Inc. | 5.20% | 3.23M | 13G | Feb 3, 2026 |
Form 4
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Sep 8, 2026 | Mads Bodenhoffofficer: SVP & PAO | Sale | 3,000 | $270.19 | 0 |
| Sep 2, 2026 | Lars Holtugdirector | Sale | 236 | $264.13 | 4,000 |
| Aug 14, 2026 | Jean Jacques Bienaimedirector | Purchase · 2 lots | 2,000 | $246.33 | 2,900 |
| Jun 2, 2026 | Scott Thomas Smithofficer: EVP & Chief Financial Officer | Purchase | 100 | $219.00 | 4,367 |
| May 29, 2026 | Scott Thomas Smithofficer: EVP & Chief Financial Officer | Purchase | 250 | $223.32 | 4,267 |
| May 29, 2026 | Jean Jacques Bienaimedirector | Purchase · 3 lots | 500 | $223.12 | 900 |
| May 26, 2026 | Jean Jacques Bienaimedirector | Purchase · 2 lots | 400 | $237.80 | 400 |
| May 11, 2026 | Flemming Steen Jensenofficer: See Remarks | Sale | 19,460 | $238.49 | 0 |
House and Senate disclosures
Not reported.